Chitosan Enhances Intestinal Health in Cats by Altering the Composition of Gut Microbiota and Metabolites

被引:6
作者
Mo, Ruixia [1 ]
Zhang, Mingrui [1 ]
Wang, Haotian [1 ]
Liu, Tianyi [1 ]
Liu, Pan [1 ]
Wu, Yi [1 ]
机构
[1] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100193, Peoples R China
关键词
cat; chitosan; intestinal health; gut microbiota; SCFAs; OLIGOSACCHARIDES; INFLAMMATION; FERMENTATION; MECHANISMS; CYTOKINES; CANINE;
D O I
10.3390/metabo13040529
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interaction between gut microbiota and the health of the host has gained increasing attention. Chitosan is a natural alkaline polysaccharide with a wide range of beneficial effects. However, rare studies have been observed on the effects of dietary chitosan supplementation on intestinal health in cats. A total of 30 cats with mild diarrhea were divided into three groups, receiving a basic diet with 0 (CON), 500 (L-CS) or 2000 (H-CS) mg/kg chitosan. Samples of blood and feces were collected and analyzed for serology and gut microbiota composition. The results demonstrated that chitosan alleviated symptoms of diarrhea, with enhanced antioxidant capability and decreased inflammatory biomarker levels in serum. Chitosan reshaped the composition of gut microbiota in cats that the beneficial bacteria Allobaculum was significantly increased in the H-CS group. Acetate and butyrate contents in feces were significantly higher in the H-CS group in comparison to the CON group (p < 0.05). In conclusion, the addition of dietary chitosan in cats enhanced intestinal health by modulating their intestinal microbes and improved microbiota-derived SCFA production. Our results provided insights into the role of chitosan in the gut microbiota of felines.
引用
收藏
页数:14
相关论文
共 55 条
[1]   Catching a glimpse of the bacterial gut community of companion animals: a canine and feline perspective [J].
Alessandri, Giulia ;
Argentini, Chiara ;
Milani, Christian ;
Turroni, Francesca ;
Ossiprandi, Maria Cristina ;
van Sinderen, Douwe ;
Ventura, Marco .
MICROBIAL BIOTECHNOLOGY, 2020, 13 (06) :1708-1732
[2]   Cytokines and intestinal inflammation [J].
Bamias, Giorgos ;
Cominelli, Fabio .
CURRENT OPINION IN GASTROENTEROLOGY, 2016, 32 (06) :437-442
[3]  
Banerjee A, 2014, BIOMARKERS IN TOXICOLOGY, P269, DOI 10.1016/B978-0-12-404630-6.00015-4
[4]   Review article: the human intestinal virome in health and disease [J].
Carding, S. R. ;
Davis, N. ;
Hoyles, L. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (09) :800-815
[5]   Mechanisms regulating intestinal barrier integrity and its pathological implications [J].
Chelakkot, Chaithanya ;
Ghim, Jaewang ;
Ryu, Sung Ho .
EXPERIMENTAL AND MOLECULAR MEDICINE, 2018, 50 :1-9
[6]   Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications [J].
Cheung, Randy Chi Fai ;
Ng, Tzi Bun ;
Wong, Jack Ho ;
Chan, Wai Yee .
MARINE DRUGS, 2015, 13 (08) :5156-5186
[7]   Gut microbiota in human metabolic health and disease [J].
Fan, Yong ;
Pedersen, Oluf .
NATURE REVIEWS MICROBIOLOGY, 2021, 19 (01) :55-71
[8]   Nondigestible carbohydrates, butyrate, and butyrate-producing bacteria [J].
Fu, Xiaodan ;
Liu, Zhemin ;
Zhu, Changliang ;
Mou, Haijin ;
Kong, Qing .
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2019, 59 (S1) :S130-S152
[9]   Allobaculum stercoricanis gen. nov., sp nov., isolated from canin feces [J].
Greetham, HL ;
Gibson, GR ;
Giffard, C ;
Hippe, H ;
Merkhoffer, B ;
Steiner, U ;
Falsen, E ;
Collins, MD .
ANAEROBE, 2004, 10 (05) :301-307
[10]  
Horwitz W., 2010, OFFICIAL METHODS ANA, V18th